Objective
This annual conference aims at keeping legal practitioners working
with the pharmaceutical sector up-to-date on the latest relevant
regulatory developments, legislative initiatives and case law. A
particular focus will be on implications for the sector of recent EU
activities in the fields of competition law, intellectual property, as
well as pharmaceutical law.
Key topics
Competition law
- The revised competition and licensing regime for technology transfer agreements
- Reverse patent settlements and impact of the recent decision from the European Commission in Servier
- Actions for damages
Patent law and trade secrets
- Preparing for litigation before the future Unified Patent Court
- Unitary patent and supplementary protection certificates: is the current legal framework still adequate?
- A new enforcement regime for trade secrets
EU pharmaceutical law round-up
- Update on medical devices and in-vitro diagnostics
- The revised transparency policy adopted by the EMA towards access to clinical trials data
- Innovative pricing and reimbursement models
- National and EU current policies towards
access to medicinal products: off-label use, orphan drugs, national
measures against drugs shortage
- Implications of the Transatlantic Trade and Investment Partnership
Who should attend?
In-house counsel and legal or patent advisers in pharmaceutical
companies; lawyers in private practice dealing with pharmaceuticals and
medical devices; lawyers in national ministries and authorities dealing
with regulation of the sector.
Gebühren in €:
|
Standard
|
EU und ERA Mitstifter
|
Junge Juristen und andere Gruppen
|
|
Registrierung
|
|
|
|
|
|
Mehr Informationen zu den Vergünstigungen
Frühzeitige Anmeldungen
10 % bis 26.01.2015
Mögliche Ermässigungen
25 % - Für junge Juristen bis einschließlich 30 Jahre (wichtig: bitte Kopie des Personalausweises mitschicken); hauptberufliche Mitarbeiter von Universitäten oder vergleichbaren wissenschaftlichen Einrichtungen; Mitarbeiter karitativer Organisationen
40 % - Für Beschäftigte der EU;
für Beschäftigte von Mitstiftern der ERA (Bulgarien, Dänemark, Deutschland und die deutschen Länder, Finnland, Frankreich, Griechenland, Irland, Italien, Kroatien, Luxemburg, Malta, Niederlande, Österreich, Polen, Portugal, Rumänien, Schottland, Schweden, Slowenien, Slowakei, Spanien, Tschechien, Ungarn, Vereinigtes Königreich, Zypern, Stadt Trier).